1.A substantial investigation of discrepancy between patient complaints and assessment by medical personnel in chemotherapy-induced nausea
Yoshihiro Yamamoto ; Ikuo Tsukiyama ; Ryoko Inuzuka ; Hiromitsu Yabushita ; Akihiko Wakatsuki ; Katsuhiko Matsuura
Palliative Care Research 2015;10(2):142-148
Purpose: In this study, we aimed to investigate the discrepancy between interview by medical personnel using 3‒point verbal rating scale (VRS) and patient complaints using numerical rating scale (NRS) in nausea diary for chemotherapy‒induced nausea. Patients and Method: In this study, we targeted patients who received chemotherapy at the gynecology department in our hospital and who recorded information in nausea diary. The discrepancy was estimated from NRS in nausea diary and the degree of nausea obtained by medical interview at approximately the same time period. We classified it into overvaluation, undervaluation or non‒discrepancy. Result: A total of 663 cases was analyzed, and 54 patientswere enrolled. The discrepancy was 25.2% (undervaluation 5.4%; overvaluation 19.8%), and mostly overvaluation was observed. NRS in nausea diary had a significant correlation with the degree of nausea obtained by medical interview(P<0.001, r=0.66) , and the kappa statistic was 0.36. Conclusion: Ratio of non‒undervaluation is approximately 95%; hence, we conclude that interview by medical personnel using VRS accurately reflects the degree of nausea.
2.Mitral Valve and Left Atrial Myxoma Operation Using a Combined Superior Transseptal Approach.
Katsuhiko Yoshida ; Hideki Ohshima ; Fumihiko Murakami ; Yasuhiro Tomida ; Akio Matsuura ; Michiaki Hibi ; Mitsuo Kawamura
Japanese Journal of Cardiovascular Surgery 1997;26(1):6-10
The combined superior transsseptal approach (CSTA) has been used for 12 mitral or left atrial myxoma operations. This approach provided excellent exposure of the mitral valve or myxoma. This approach was compared with the transseptal and left atrial approaches in 1 and 3 cases, respectively. There were no differences in operative time, cardiopulmonary bypass time, anoxic time, bleeding volume, blood transfusion volume and postoperative arrhythmic complications. We use CSTA for cases with tricuspid valve disease, small left atrium, reoperation and left atrial myxomas.
3.Three Cases of Right Atrial Separation for Chronic Atrial Fibrillation with Atrial Septal Defects.
Shinji Hirai ; Taijiro Sueda ; Katsuhiko Imai ; Kenji Okada ; Satoru Morita ; Kazumasa Orihashi ; Yuichiro Matsuura
Japanese Journal of Cardiovascular Surgery 1998;27(6):364-366
Atrial fibrillation is common in adults with atrial septal defect. A right atrial separation procedure was performed for the ablation of atrial fibrillation during the concomitant repair of atrial septal defect. The operation was performed under cardiopulmonary bypass. A Y-shape incision was made in the right atrium, followed by cryoablation of the tricuspid annulus and the atrial septum. After the operation, all three patients recovered and maintained a normal sinus rhythm during follow-up periods of 12, 4, and 1 months. This is a simple and effective procedure for the elimination of chronic atrial fibrillation associated with atrial septal defects in adults.
4.Effect of tramadol on cancer pain in a patient with advanced endometrial carcinoma and myasthenia gravis: a case report
Yoshihiro Yamamoto ; Maki Todo ; Kikuyo Nishida ; Keita Iwasaki ; Chiharu Suzuki ; Miki Kondo ; Shoko Kinoshita ; Kazuyo Kanbara ; Hiromitsu Yabushita ; Akihiko Wakatsuki ; Katsuhiko Matsuura ; Mari Nishihara ; Kenichi Arai
Palliative Care Research 2013;8(2):570-574
Introduction: Tramadol (TRM) has been included as a weak opioid at the second step of the WHO analgesic ladder and has been widely used in palliative medicine. Here we report a case of amelioration of cancer pain by TRM therapy in a female patient with myasthenia gravis (MG). Case:The patient was a 70’s woman who was diagnosed with advanced endometrial carcinoma and suffered from chest pain caused by chest metastasis. 25 mg of a TRM capsule was orally administered three times a day. The dose was increased to 50 mg twice a day. It was resulted in sound pain relief with transient muscle weakness but without a myasthenic crisis.